(MedPage Today) — Statin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and hepatic decompensation, researchers found.
In a cohort of 16,501 individuals with chronic liver disease…
Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/114687
Author :
Publish date : 2025-03-17 17:06:00
Copyright for syndicated content belongs to the linked Source.
